
KIORA PHARMACEUTICALS INC
KIORA PHARMACEUTICALS INC (KPRX)
WebsitePrice
Market cap
Next catalystExpected Q3 2027KIO-301 — retinitis pigmentosa · Phase 2 dataCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2FilingApproved
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P2FilingApproved
PreINDP1P3FilingApproved
Other pipelines
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved